posted
Stochs and RSI bearish? Really? I'm pretty new to chart reading but I read them as bullish also (daily chart)... Slow Stochs shooting straight up about to cross 70... RSI also shooting straight up about to cross 60. Am I mis-reading something here?
Posts: 157 | From: IL | Registered: Jul 2005
| IP: Logged |
posted
Attack? LOL...we are all here for a continuing education...LOL....I am definitely included.
BRB checking out something else for this one!
on Today at 2:01pm, QuestSolver wrote:trying to figure out the dip cycle on this one,kinda hard so far.Might get a dip within the next 15 minutes or so but buy presuure is high just below bid.I doubt we get mamy DT exits near close today since volume is to low for most to play or flip.
damn called that dip almost to the minute!! lucky guess huh.....LOL....going back up already.
posted
At the moment MMs need shares. We MAY close strong. Chart looking good but market still bearish for all stock.
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
By BETSY MCKAY Staff Reporter of THE WALL STREET JOURNAL October 5, 2005
Two teams of scientists reported that they re-created the influenza virus that killed as many as 50 million people in 1918 and 1919. The findings suggest that the threat of an avian-flu pandemic might be greater than previously thought.
Researchers from the Armed Forces Institute of Pathology, the Centers for Disease Control and Prevention and Mount Sinai School of Medicine said that the historic, killer flu-bug strain probably originated as an avian bug and then spread in humans without undergoing complicated changes that many experts had thought necessary for a human pandemic.
Their findings, published today in the journals Nature and Science, create "cause for concern" and make getting to the bottom of the 1918 flu outbreak far more than an historical exercise, said Jeffery Taubenberger, the Armed Forces Institute researcher who led one of the studies.
Fears are growing over the continuing spread of avian flu, which has become widespread in poultry flocks and is jumping to humans with increasing frequency. The lethal strain, known as H5N1, has claimed 60 lives in Indonesia, Vietnam, Thailand and Cambodia since late 2003.
Most of those cases were in people who had direct contact with infected poultry, but fears are growing that the highly contagious virus could mutate and begin spreading between humans. President Bush said on Tuesday that he would consider using the military to enforce quarantines in the event of an outbreak in the U.S.
The findings by Dr. Taubenberger and his team of researchers, published in Nature, follow a nine-year effort to decode the 1918 strain by sequencing its eight genes. The research concluded that the pandemic flu outbreak was most likely caused by an avian virus. The scientists also discovered 10 mutations that distinguish the 1918 virus from avian bugs, suggesting changes that the virus made to adapt to a human host, they said. They also noted that some of those mutations are also present in the currently circulating H5N1 virus, suggesting it could make the jump to humans in a similarly rapid and alarming way.
In the second study, published in Science, scientists from the CDC and Mount Sinai took the decoded virus and re-created it, using a process known as reverse genetics. The virus they created, in a secure CDC lab, was "exceptionally virulent," quickly killing embryonated chicken eggs and mice, said Terence Tumpey, a senior scientist at the CDC who led the effort. The team also found that the 1918 bug had an unusual ability to penetrate cells that flu bugs don't usually reach deep in the lungs, providing some clues as to why its symptoms were so severe.
While the research significantly advances scientists' understanding of the avian-flu threat, it also raises concerns about keeping the virus from escaping from the lab or into the hands of bioterrorists. Dr. Tumpey said the experiments were approved ahead of time by two CDC committees with internal and external experts, and were conducted under strict safety and security standards. <<
Posts: 1364 | From: Somebody from Europe | Registered: Sep 2005
| IP: Logged |
posted
might try to buy another small block at the bid or just above and see if I get lucky,along with AMEP I don't mind holding a good stock thru the weekends!
posted
still no luck,shares locked up I guess,won't even give me a tweener just under the ask!This is going to look much better in the upcoming weeks imo!
posted
Quest: Yesterday I bought a few hundred dollars AT the ask and it took several minutes for them to fill me. And that was a tiny order. Shares are incredibly tight on this one.
Posts: 133 | From: Blacksburg, VA | Registered: Sep 2005
| IP: Logged |
posted
Sounds like after we make our fortunes on AMEP and this stock... we all need to buy log cabins in the mountains!
Posts: 157 | From: IL | Registered: Jul 2005
| IP: Logged |
posted
mmalone...no doubt about it,much differant then AMEP but when these low floaters take off MM's will scrounge and entice for shares and move the bid fast!
posted
Thanx Bmax,I think we now have two great stocks to be in and carry into the new year,AMEP and CLBE
as for CLBE
In the recent 10-q they clearly state they may be profitable THIS year and heck we are in the last quarter now.The potential for their new adult stem cell extraction is going to be the most and probably the only used method very soon and if we get the news on the patent approval for this its going to change the whole outlook for this company and its subs,even major religous leaders are now backing this method eliminating the controversal embryo issue altogether giving the new method a higher moral standing in our social system.CLBE is definitey not a flipper,its a strong BUY and HOLD in your long term or mid term portfolio.This is one I recommended directly to family members myself,with some contacts I have been dealing with out west in this sector they have clearly stated something very important is in the works in stem cell methods and reseach and may be released next week,this could effect all companies involved in stem cells I guess.
The Catholic Church in Korea has decided to donate money for adult stem cell research. The move comes amid strong Vatican opposition to embryonic stem cell research and is reflects support for research into an alternative. The Church has been among the most vocal opponents of embryonic stem cell research based on the belief that embryos are human beings. In Korea, a country leading that field of science, the Catholic Church is donating millions of dollars to aid research involving adult stem cells in the hope of reducing the increasing reliance on embryonic stem cells to treat hard-to-cure diseases.
"The research harms the integrity of life, and that's why we cannot accept the use of embryos," the church said. It wants to fund research on adult stem cells derived from bone marrow or umbilical cords that would otherwise be discarded after a baby is born. They say this is more practical and does not cause ethical controversy.
The Seoul Diocese set up a committee to donate W10 billion (US$10 million). The church said it will not assist the research of Korea's Dr. Hwang Woo-suk who grabbed the world's attention last year by announcing the successful cloning of a human embryo. Catholics have criticized Hwang since his work involved using human eggs and destroying embryos to harvest stem cell batches.
Embryonic stem cells have the potential to become any cell or tissue of a human body like bone, skin or blood. In contrast, adult stem cells, which can be harvested from adult patients, can only be used to create specific cell types like muscle tissue from muscle stem cells. The decision by the Seoul Diocese may still fuel an ongoing debate between religious and academic groups over the desired type of stem cell research.
posted
Pro-Life Congressman and Dr. J Seek Adult Stem Cell Research Bill
Washington, DC (LifeNews.com) -- A leading pro-life congressman and former Philadelphia 76ers basketball star Julius "Dr. J" Erving teamed up at a press conference Thursday to ask the Senate to pass a House-approved bill that would promote adult stem cell research using umbilical cord blood. The bill provides funding to use stem cells from umbilical cord blood, which have proven to be the most effective and the House approved HR 2520 434-1 in May.
The Senate has stalled on voting for the bill because it has gotten caught up in the divisive debate over using taxpayer funds for embryonic stem cell research. Smith asked that the Senate not delay any further on voting on the bill.
"Delay is denial, especially for the sick who will not benefit from cord blood transplantation because the Senate inexplicably delayed," Smith said. "Make no mistake, for these sick children and adults, this is a matter of life or death."
Dr. J, who is currently the Vice President of the Orlando Magic, said African American patients need the bill to be approved because they have a much lower chance to obtain a match within the current bone marrow and umbilical cord blood stem cell inventories.
"Each year, thousands of Americans die who could be saved if larger and more diverse inventories of umbilical cord stem cells were in existence," Erving noted. "I came today to join Congressman Smith in asking the Senate to finish the job and pass this legislation and provide doctors the resources they need to treat the thousands of courageous patients in desperate need of help."
Currently, some minorities have less than a 50% chance of obtaining a potentially life saving transplant
Umbilical cords are a rich, non-controversial source of stem cells. Currently hospitals throw millions of them away each year because the infrastructure required to properly collect and store them is not available.
Thousands havebeen successfully treated with cord blood stem cells for more than 67 diseases including Leukemia and Sickle Cell Anemia.
The infusion of federal funds will make this medical miracle available to thousands more and will ensure that research continues so that this source of stem cells can treat many other debilitating diseases.
Numerous doctors and patients who have been treated with umbilical cord stem cells also attended the press conference.
Medical studies into embryonic stem cells have failed and it was time to get behind alternative research, Nationals Senate leader Ron Boswell says.
Three years ago, after a passionate debate, federal parliament passed laws giving scientists access to unwanted human embryos for research purposes.
Since then the national scientific regulator has issued nine licences for such research.
But Senator Boswell told parliament on Wednesday the research had come to nothing and support should now be given to alternative research on adult stem cells.
"The last debate was a very difficult one for many of us and led to deep searching over ethical issues involved," Senator Boswell told parliament.
"My point is that for all the pain we went through, for all the cost, we are not even close to the promised cures from embryo research.
"Yet there is true hope out there that medical research will tackle the most painful and debilitating diseases known to humanity and it will do it through adult stem cell technology.
"The only question is how long before the world wakes up to it.
"We have before us a sober opportunity to change direction to a zone of scientific research that is free of ethical dilemmas."
Senator Boswell said research had shown that adult stem cells provided a viable alternative to embryonic stem cells.
He said researchers at Queensland's Griffith University had successfully grown adult stem cells harvested from the olfactory mucosa, the organ of smell in the human nose.
They demonstrated the cells can give rise not only to nerve cells but also to heart, liver, kidney, and muscle cells.
The research team, led by Professor Alan Mackay-Sim has spent the past four years developing the research, particularly investigating the potential of stem cells in treating Parkinsons disease.
Senator Boswell's speech came as Industry Minister Ian Macfarlane was planning a forum for federal MPs next week to consider the issues surrounding stem-cell technologies.
Mr Macfarlane warned earlier this week that Australia's reputation as a global player in biotechnology could be undermined if conservative forces succeeded in banning embryonic stem-cell research.
posted
Date: Saturday, October 08, 2005 9:03:09 AM EST By STEVE MITCHELL, Senior Medical Correspondent
WASHINGTON, Oct. 8 (UPI) -- Researchers said Saturday they have used stem cells collected from the amniotic fluid surrounding fetal lambs to grow windpipes, and then implanted the tissue back into the fetuses while they were still in the womb -- a breakthrough that could lead to ways to repair congenital defects before birth.
Defects in the windpipe or trachea are rare in humans, but they can be life-threatening and are difficult to repair. Often, the fix -- involving surgery soon after birth -- can be fraught with complications, including brain damage.
Dr. Dario Fauza and colleagues at Children's Hospital in Boston hope their technique can offer a way around such problems by repairing the defect before the baby is born.
"The fetus doesn't need the trachea, so the repair would have time to heal in utero," Fauza said in a statement, "and fetal healing is very good -- it's better than adult healing."
The technique involves extracting amniotic fluid, which surrounds the fetus in the womb, to obtain a type of stem cells known as mesenchymal stem cells. These cells arise directly from embryonic stem cells and they can give rise to various cell types, so they could be used to regenerate damaged or diseased tissues.
posted
Congradulation QuestSolver for this pick. Good one. It will raise like CBAI for sure. Meanwhile have a look on CTUM. Chart look very good and only 7 millions in the float. I have been playing with it all week. Each time I order 5000 shares the ask was moving up...So with some buying pressure, CTUM could hit .39 cent in one day.
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
posted
Thanx Forrest,was looking at that Friday but took no position,at least not yet,had no loose money because I was dumping as much as I could into CLBE.I still hold my AMEP for the ONG now.
the following companies are in stem cell research.
ASTM $2.20
STEM $5.04
GERN $9.86
VIAC $5.49
get an idea where CLBE could go now especially with the new adult stem cell extraction tech that is patent pending with no ethical or moral issues attached?
I saw a show on the tube a short while back where they took the patients own stem cells from up in their nasal cavity and put the stem cells on the affected nerves. In this case there were three women and they were all paralyzed in the legs from accidents. They were like that for years, but after receiving the stemcells they actually had movement in their legs.
The prognosis was that in time they may walk again with this type of treatment. I was dumbfounded and had never seen anything like this before. The three women were very hopeful and you could tell that something great was happening. I think adult stem cells and cord blood offer the best hope at this time for any advances made in this kind of therapy. I'm loading up on Monday. Hope I'm right
my response...
Whinny...thats just the tip of the mountain for adult stem cell research,this is going to reveal unprecidented results in healing and CLBE with its patent pending on stem cell extraction from adults could easily become a top player so if your buying Monday at open,you will get hell even buying at the ask imo.
posted
I think soon many will realize how lucky they were when they made even a small entry at these levels,as for CLBE I believe the reason it took a drop in late July and early August from .20 to the single digits may be related to the PR on August 2 concerning the deal that was made with AGORA. AGORA has been retained by CalbaTech for a period of 12 months. AGORA will be compensated with both a monthly monetary fee and stock options, vesting 50,000 shares per quarter, at $.20 per share.This agreement has been negotiated entirely at arm's length. AGORA is located in Toronto, Ontario. I think it is only a temporary effect and I have and will continue to take advantage of this as much as I can because there is almost zero resistance between .07 to .125 and from there it should glide back into the .20's quick and any whisper of the patent approval then this will be a completely new ballgame.
posted
QuestSolve continue to informe us. I do agree with you all the way because and I see what you mean with this stock. Alot of people on this board do prefere invest in Pink sheet than OTCBB. They like to buy million of shares instead of few one and trying to figure out how to make big buck quickly with stock like QBID, ICAN... They don't like when we suggest or promote other stock with more potential. They call us pumper....
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
posted
I recently suggest CTUM and CNCN. I have been describe as a pumper by clintoj. This guy promote GZFX and look now where this stock is... We all make mistake sometime...I use Chart and news. My play til december: CLBE, CTUM and CNCN. Except for CNCN, very very bullish chart.
posted
Thats what I don't understand either,face it..information changes every second in our world now.So by us putting out new DD or more detailed info on a company is called pumping? I always considered pumping as post that have CAPITOL ONE LINERS and GOING TO THE MOON! etc...but posting real verifiable info thats up to date I never considered pumping at all especially when providing links to the sources!
It was announced by CEO last year or early this year CLBE would be buying up some open shares. Now seems like a good time. Hope to read about it in future 10-Q's that they got some, is this still on the horizon?
Subject: CLBE buying shares From comtek PostID 426099 On Saturday, October 08, 2005 (EST) at 7:05:28 AM
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
